Systemic Hormonal Contraceptive Use Is Associated With Greater Odds of Rotator Cuff Tears, Shoulder Instability, Dislocation, and Other Shoulder Pathologies: A Propensity Matched Epidemiological Study
Arthroscopy · 2026
DOI: 10.1002/arj.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthroscopy, 2026. Verfasst von Argen Omurzakov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A. Hauptthemen laut MEDLINE: Rotator Cuff Injuries, Joint Instability, Shoulder Dislocation, Contraceptive Agents, Hormonal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate whether systemic estrogen‐only, progestin‐only, or combined hormonal contraceptives (HCs) are associated with increased risk of shoulder pathologies in reproductive‐age females.
Methods
A retrospective cohort study of female patients presenting to clinic from 2013 to 2020 and aged 13‐50 with 5 years of follow‐up was conducted using the TriNetX database. Patients prescribed estrogen‐only, progestin‐only, or combined HCs were matched 1:1 to controls using propensity score matching. Odds ratios (ORs) 95% confidence intervals (CIs), and P values were calculated after 5 years for 10 shoulder pathologies.
Results
Estrogen‐only (n = 95,109) users had increased odds of rotator cuff tears (RCT; OR: 2.0, P < .001), shoulder instability (SI; OR: 1.5, P < .001), bursitis (B; OR: 2.0, P < .001), superior glenoid labral tears (SLT; OR: 1.8, P < .001), impingement (IMP; OR: 1.8, P < .001), and calcific tendinitis (CT; OR: 1.8, P < .001), with no difference in rotator cuff capsule sprains (CS; OR: 1.3, P = .117), dislocation or subluxations (DS; OR: 1.3, P = .069), acromioclavicular (AC) joint sprains (AC‐S; OR: 1.3, P = .272), or AC joint dislocations (AC‐D; OR: 1.2, P = .486). Progestin (n = 766,264) and combined (n = 625,809) users had increased odds for all pathologies (all P < .05), with ORs for RCT, SI, CS, DS, B, SLT, IMP, CT, AC‐S, and AC‐D of 1.6, 1.6, 1.3, 1.5, 1.5, 1.4, 1.6, 1.5, 1.6, and 1.2 for progestin, and 1.6, 1.6, 1.7, 1.4, 1.7, 1.6, 1.8, 1.6, 1.8, and 1.3 for combined HC users.
Conclusions
The HC formulations studied were associated with increased odds of all 10 shoulder pathologies. Surgeons should be aware of these potentially increased risks when treating patients on HCs. Level of Evidence Level III, retrospective cohort study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
- Weill Cornell Medical College, New York, New York, U.S.A.
- UH Drusinsky Sports Medicine Institute, Cleveland, Ohio, U.S.A.
ORCID-Profile: Argen Omurzakov, Aakash K Shah, Jacob G Calcei
Zitieren
APA
Omurzakov, A., Omurzakov, A. M., Burkhart, R. J., Shah, A. K., Abid, R., Voos, J. E., Calcei, J. G., & Apostolakos, J. M. (2026). Systemic Hormonal Contraceptive Use Is Associated With Greater Odds of Rotator Cuff Tears, Shoulder Instability, Dislocation, and Other Shoulder Pathologies: A Propensity Matched Epidemiological Study. Arthroscopy. https://doi.org/10.1002/arj.70201
Vancouver
Omurzakov A, Omurzakov AM, Burkhart RJ, Shah AK, Abid R, Voos JE, et al. Systemic Hormonal Contraceptive Use Is Associated With Greater Odds of Rotator Cuff Tears, Shoulder Instability, Dislocation, and Other Shoulder Pathologies: A Propensity Matched Epidemiological Study. Arthroscopy. 2026. doi:10.1002/arj.70201
BibTeX
@article{Omurzakov2026,
author = {Omurzakov, Argen and Omurzakov, Arsen M and Burkhart, Robert J and Shah, Aakash K and Abid, Rayyan and Voos, James E and Calcei, Jacob G and Apostolakos, John M},
title = {Systemic Hormonal Contraceptive Use Is Associated With Greater Odds of Rotator Cuff Tears, Shoulder Instability, Dislocation, and Other Shoulder Pathologies: A Propensity Matched Epidemiological Study},
journal = {Arthroscopy},
year = {2026},
doi = {10.1002/arj.70201}
}
EUVIMED